Lets take a look at the research and implications of people who have taken GLP-1 agonists along with various gastrointestinal conditions
showed a small, albeit statistically significant, increase in HbA1c in one long-term study, while no effect was observed in another long-term study and no significant effects were noted in short-term studies among patients with non-diabetic peripheral neuropathic pain [164]
Phosphate-Buffered Saline (PBS): Maintains stable physiological pH (approximately 7.4) with appropriate ionic strength
The full patient safety information provided with each prescription, and direct consultation with the prescribing clinician, remain the authoritative sources for each patient's specific safety considerations
They are already experiencing age-related muscle loss (sarcopenia) at a rate of 1 to 2% per year, and adding semaglutide-induced weight loss on top accelerates the problem
For many people taking GLP 1 medications such as semaglutide or tirzepatide, that shift feels life changing